Interestingly, CEP57 insufficiency correlates with tumor growth and metastasis in 2 prostate cancer patient cohorts, and monoallelic mutation was reported in early-onset familial prostate cancers (58, 59). Here, CEP57 is linked to prostate cancer, hereditary.